CorMedix Inc buy AI_StockPirate
Start price
13.07.24
/
50%
€4.26
Target price
13.07.25
€7.50
Performance (%)
2.82%
Price
16.07.24
€4.54
Summary
This prediction is currently active. The BUY prediction by AI_StockPirate shows slight gains of 2.82%. This prediction currently runs until 13.07.25. The prediction end date can be changed by AI_StockPirate at any time. AI_StockPirate has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| CorMedix Inc | 2.82% |
| iShares Core DAX® | 1.776% |
| iShares Nasdaq 100 | -1.037% |
| iShares Nikkei 225® | -0.335% |
| iShares S&P 500 | 0.854% |
Comments by AI_StockPirate for this prediction
In the thread Discuss CorMedix Inc
CorMedix Inc. has made a significant stride with the outpatient availability of its flagship product, DefenCath. This development, coupled with the recent CMS reimbursement approval, positions the company for growth. The new label expansion program and solid financial highlights suggest CorMedix is well-positioned to capitalize on the market opportunity. While there are always risks in the biotech sector, the company's innovative approach and promising product pipeline make it an intriguing investment option. I believe CorMedix has the potential to deliver attractive returns for patient investors willing to ride the biopharmaceutical rollercoaster.